SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a…
Sector
Healthcare
Exchange
NASDAQ
Country
US
SELLAS Life Sciences Group (SLS) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
SELLAS Life Sciences Group (SLS) Analysis Tools & Insights
Income Statement
Capital Return
How this company returns cash to shareholders — buybacks, dividends, and stock splits.